Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RVMD
#466
Revolution Medicines, Inc. Common Stock
144.250
0
USD
+5.83%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+5.83%
Monthly Change
+49.33%
6 month change
+160.38%
Year Change
+160.38%
Previous Close
136.300
0
Open
144.140
0
Bid
Ask
Low
143.170
0
High
144.430
0
Volume
1 481
Markets
US Stock Market
Healthcare
RVMD
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
73.38 M
74.19 M
90.49 M
164.69 M
185.91 M
198.17 M
—
Valuation ratios
Enterprise value
2.8 B
1.76 B
1.92 B
3.95 B
7.59 B
15.4 B
36.94 B
Price to earnings ratio
0.09
0.01
-7.45
-7.31
-12.22
-13.39
-39.38
Price to sales ratio
-0.22
-0.05
52.3
275.84
—
—
—
Price to cash flow ratio
0.09
0.01
-8.25
-9.11
-13.16
-16.87
-48.17
Price to book ratio
-0.02
-0
2.7
1.75
3.24
9.28
12.02
Enterprise value to EBITDA ratio
-25.91
-9.51
-7.53
-7.85
-10.44
-12.82
-35.79
Profitability ratios
Return on assets %
-0.19
-0.25
-0.31
-0.21
-0.23
-0.48
-0.48
Return on equity %
-0.23
-0.31
-0.36
-0.24
-0.26
-0.69
-0.65
Return on invested capital %
-316.06
-464.6
-568.63
-926.42
-1 008.19
-1 170.61
—
Gross margin %
100
100
100
100
—
—
400
Operating margin %
-257.54
-639.7
-730.01
-4 207.12
—
—
-155.81 K
EBITDA margin %
-251.46
-629.21
-718.79
-4 346.11
—
—
-157.72 K
Net margin %
-251.63
-636.58
-702.95
-3 768.28
—
—
-149.67 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
9.63
9.77
10.65
13.06
14.2
7.14
40.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.05
0.05
0.01
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
424.34
2 455.33
-2.78
-3.1
-3.32
-4.72
-4.75
EBIT per share
469.43
3 136.45
-3.2
-4.31
-4.11
-6.22
-6.23
EBITDA per share
458.36
3 085.01
-3.15
-4.45
-4.33
-6.32
-6.33
Total debt per share
—
—
—
—
—
—
—
Cash per share
-1 869.05
-9 626.71
8
16.38
13.65
10.65
43.37
Net current asset value per share
-1 925.8
-9 838.9
8.19
16.61
13.88
10.91
44.25
Tangible book value per share
-1 692.56
-8 809.77
7.59
15.5
13.08
8.21
36.46
Working capital per share
-1 725.74
-8 832.11
7.42
15.34
12.9
9.39
39.6
Book value per share
-2 012.96
-10.05 K
8.5
16.14
13.5
8.58
37.96
News
Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today (NYSE:JNJ)
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
Stocks Settle Higher in Hopes for an Agreement to End the Iran War
Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)
Stocks Recover as Oracle Leads Software Companies Higher
Stocks Retreat as US Set to Blockade the Strait of Hormuz
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound?
Harbor Health Care ETF Q4 2025 Portfolio Review
This One Data Readout Could Make Or Break Revolution Medicines (NASDAQ:RVMD)